Sanofi SA (NASDAQ:SNY)
| 55.20 Delayed Data As of May 27 |  -0.30 / -0.54%Today’s Change | 46.93 Today|||52-Week Range 58.10 | +10.18% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $136.2B |
Company Description
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Contact Information
Sanofi 54, rue La Boétie Paris Ile-de-france 75008 |
Employees
Shareholders
| Other institutional | 5.37% |
| Mutual fund holders | 4.58% |
| Individual stakeholders | -- |
Top Executives
| Paul Hudson | Chief Executive Officer & Director |
| Jean-Baptiste Chasseloup de Chatillon | Chief Financial Officer & Executive Vice President |
| Nestle Frank | Global Head-Immunology Therapeutic Research Area |
| John C. Reed | EVP & Global Head-Research & Development |
| Dietmar P. Berger | Chief Medical Officer & Global Head-Development |
